Studies on tirzepatide (mounjaro), including Phase 2 trials and data from the SURPASS programme, provide valuable insights into the potential benefits of microdosing
Tell your doctor or pharmacist if you are taking other products that cause drowsiness such as opioid pain or cough relievers (such as codeine, hydrocodone), alcohol, marijuana (cannabis), drugs for sleep or anxiety (such as alprazolam, lorazepam, zolpidem), muscle relaxants (such as carisoprodol, cyclobenzaprine), or other antihistamines (such as diphenhydramine, promethazine)
Some patients report that night-time dosing allows them to sleep through initial side effects, though there is no conclusive clinical evidence that timing categorically reduces nausea
The method used matters as it can be most of the time taken orally or by intraveinous injections
In subjects treated with ALCAR 1.5 g/day, the difference in ALSFRS-R slope as compared to not treated was 0.4 (95% CI 0.0, 0.7